Zobrazeno 1 - 10
of 59
pro vyhledávání: '"Hans Weiher"'
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 43, Iss 1, Pp 1-18 (2024)
Abstract A firm link between endoplasmic reticulum (ER) stress and tumors has been wildly reported. Endoplasmic reticulum oxidoreductase 1 alpha (ERO1α), an ER-resident thiol oxidoreductase, is confirmed to be highly upregulated in various cancer ty
Externí odkaz:
https://doaj.org/article/500a17bba7f641ce9780392d3808f1fd
Autor:
Yutao Li, Amit Sharma, Michèle J. Hoffmann, Dirk Skowasch, Markus Essler, Hans Weiher, Ingo G. H. Schmidt-Wolf
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
IntroductionA multitude of findings from cell cultures and animal studies are available to support the anti-cancer properties of cannabidiol (CBD). Since CBD acts on multiple molecular targets, its clinical adaptation, especially in combination with
Externí odkaz:
https://doaj.org/article/bfc97979b5284464be438b1f21ebb638
Autor:
Ying Zhang, Xiaolong Wu, Amit Sharma, Hans Weiher, Matthias Schmid, Glen Kristiansen, Ingo G. H. Schmidt-Wolf
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Cytokine-induced killer cells (CIK) in combination with dendritic cells (DCs) have shown favorable outcomes in renal cell carcinoma (RCC), yet some patients exhibit recurrence or no response to this therapy. In a broader perspective, enhancing the an
Externí odkaz:
https://doaj.org/article/39d548e8fb154f9bb55a4c360eb78b2e
Autor:
Yutao Li, Amit Sharma, Xiaolong Wu, Hans Weiher, Dirk Skowasch, Markus Essler, Ingo G. H. Schmidt-Wolf
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundCancer heterogeneity poses a serious challenge concerning the toxicity and adverse effects of therapeutic inhibitors, especially when it comes to combinatorial therapies that involve multiple targeted inhibitors. In particular, in non-small
Externí odkaz:
https://doaj.org/article/5be8c8838963451e8c97d2ad2c5c30b4
Autor:
Xiaolong Wu, Amit Sharma, Johannes Oldenburg, Hans Weiher, Markus Essler, Dirk Skowasch, Ingo G. H. Schmidt-Wolf
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
Cytokine-induced killer (CIK) cells are an ex vivo expanded heterogeneous cell population with an enriched NK-T phenotype (CD3+CD56+). Due to the convenient and relatively inexpensive expansion capability, together with low incidence of graft versus
Externí odkaz:
https://doaj.org/article/b6cb359295e6480ea386c169e5f94792
Autor:
Ingo G.H. Schmidt-Wolf, Michael H. Muders, Eugenia V DÍez GarcÍa De Olalla, Sarah Förster, Hans Weiher, Francesca Garofano
Publikováno v:
Anticancer Research. 40:5489-5496
Background/aim Cytokine-induced killer (CIK) cells are a heterogenous population of immune cells showing promising applications in immunotherapeutic cancer treatment. Neuropilin (NRP) proteins have been proven to play an important role in cancer deve
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::abf4e6bed67305c40ed42c8706d01408
https://doi.org/10.21873/anticanres.14560
https://doi.org/10.21873/anticanres.14560
Autor:
Maria Fitria Setiawan, Ingo G.H. Schmidt-Wolf, Teresa Lozano, Francesca Garofano, Hans Weiher, Oliver Rudan, Roland Schmidt-Wolf, Bettina Langhans, Noelia Casares, Juan José Lasarte, Christian P. Strassburg, Annabelle Vogt, Maria A. Gonzalez-Carmona
Publikováno v:
Anticancer Research. 39:5369-5374
Background/aim Cytokine-induced killer (CIK) cells are ex vivo expanded major histocompatibility complex (MHC)-unrestricted cytotoxic cells with promising effects against a variety of cancer types. Regulatory T-cells (T-reg) have been shown to reduce
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a17dad477aac81c1c16258d0bd3f294e
https://doi.org/10.21873/anticanres.13730
https://doi.org/10.21873/anticanres.13730
Publikováno v:
International Journal of Molecular Sciences
Volume 21
Issue 9
Int. J. Mol. Sci. 2020, 21(9), 3078
International Journal of Molecular Sciences, Vol 21, Iss 3078, p 3078 (2020)
Volume 21
Issue 9
Int. J. Mol. Sci. 2020, 21(9), 3078
International Journal of Molecular Sciences, Vol 21, Iss 3078, p 3078 (2020)
Cytokine-induced killer (CIK) cells are heterogeneous, major histocompatibility complex (MHC)-unrestricted T lymphocytes that have acquired the expression of several natural killer (NK) cell surface markers following the addition of interferon gamma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c76c2a5fabbfa5ec3bd1a115225bf73f
Autor:
Nkem Purity C. Emekwue, Ommega Internationals, Ingo Schmidt-Wolf, Hans Weiher Ingo G.H. Schmidt-Wolf
Publikováno v:
International Journal of Hematology and Therapy. 4:16-24
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bf8d7cc55cb40d0b570558110044c633
https://doi.org/10.15436/2381-1404.18.1666
https://doi.org/10.15436/2381-1404.18.1666
Autor:
Ingo G.H. Schmidt-Wolf, Amit Sharma, Ying Zhang, Matthias Schmid, Hans Weiher, Glen Kristiansen
Publikováno v:
Cancers
Cancers 2021, 13(23), 6007
Cancers, Vol 13, Iss 6007, p 6007 (2021)
Cancers 2021, 13(23), 6007
Cancers, Vol 13, Iss 6007, p 6007 (2021)
Simple Summary Lymphoma is a heterogeneous group of neoplasms including over 70 different subtypes. Its biological characteristic of deriving from lymphoid tissues makes it ideal for immunotherapy. In this paper, we provide insights into lymphoma-spe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bcebf1958372784c27ec1d103cf3f6c6
https://doi.org/10.3390/cancers13236007
https://doi.org/10.3390/cancers13236007